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To the Editor, Biology and Bone Marrow Transplantation 
 
Philippe Ratajczak, Ph.D. 
Allison Desveaux 
Gérard Socié, M.D., Ph.D. 
Anne Janin, M.D., Ph.D.
 Alveolar hemorrhage and acute graft versus host disease. 
 
The very complete study of Majhail and al 
1
 on diffuse alveolar hemorrhage (DHA) 
and infection-associated alveolar hemorrhage (IAH) following hematopoietic stem cell 
transplantation (HSCT) highlights significant points: the overlap between DAH and IAH in a 
large series of transplanted patients, the better survival of patients with early-onset alveolar 
hemorrhage, the allogeneic donor source and severe acute graft versus host disease (GVHD) 
as risk factors independently associated with increased incidence of post-HSCT alveolar 
hemorrhage. 
These thoroughly analyzed clinical data are in accordance with the experimental data 
we obtained in a murine model of allogeneic splenocytes transferred into immunodeficient 
mice 
2
. This model, devoid of conditioning, offers the opportunity to study the cell and tissue 
lesions induced by the allogeneic reaction, without interference from radiotherapy sequels. 
We showed that endothelial cells of all organs, including lungs, were early targets of the 
allogeneic reaction, and that damaged endothelial cells underwent apoptotic death mediated 
by Fas ligation. In the mice lungs, endothelial damage led to alveolar hemorrhage, associated 
with lymphocytic bronchitis, a pathologic feature observed in patients with GVHD 
3
. Further 
studies on human biopsies with allogeneic and autologous HSCT showed endothelial lesions 
and pericapillary hemorrhages linked to severe acute GVHD in upper digestive tract 
4
. 
Another systematic pathological study of human biopsies showed the reduction of endothelial 
cell surface in the skin of patients with chronic GVHD 
5
. Since lung biopsies are much more 
difficult and dangerous to perform than skin and duodenal biopsies, no systematic 
pathological study on human lung biopsies has been reported so far. The study of Majhail and 
al, as a previous report of pulmonary hemorrhage as a cause of death in patients with severe 
acute GVHD 
6
 supports the fact that, as in the digestive tract, severe acute GVHD contributes 
to hemorrhage in patients’ lungs through endothelial cell damage. 
Sequential study in our experimental model showed that endothelial apoptosis is an 
early damage in the allogeneic reaction, and that all endothelial cells are not at once apoptotic. 
Therefore, alveolar hemorrhage is focal in early lesions (Figure 1a), limited, as we found in 
digestive tract of patients with GVHD, to the areas where endothelial damage has been severe 
enough to be associated with capillary basal lamina rupture (Figure 1c). Diffuse alveolar 
damage (Figure 1b) occurs later and for severe acute allogeneic reactions, induced in our 
model by transfer of a high number of allogeneic lymphocytes 
2
. These experimental data are 
in accordance with one of the main points underlined by Majhail and al: the difficult 
distinction between DAH and IAH in HSCT recipients.  
The endothelial damage linked to acute allogeneic reaction, if it takes place early in 
the course of the lung disease, may also contribute to explain the more favourable outcome of 
early-onset alveolar hemorrhage in this large series of HSCT recipients. Cell death through 
apoptosis, as observed in target cells of GVHD, does not induce an inflammatory reaction 
7
. 
The vascular endothelium is composed of only one layer of endothelial cells, and apoptotic 
endothelial cells can be cleared by the blood flow 
8, 9
. Therefore, endothelial cell repair can 
more rapidly and efficiently occur after endothelial apoptosis than after whole tissue damage 
linked to infectious disease. Experimental studies have shown that endothelial repair occurs 
either through local migration and proliferation of endothelial cells adjacent to the site of 
injury, or through homing and incorporation of bone marrow-derived endothelial progenitor 
cells on the site of endothelial injury 
8, 9
. Although endothelial cell division, which may reach 
50% of the cells in and around the injured sites after induced arterial denudation 
10
, might be 
active in GVHD patients, the role of bone marrow-derived cells has been recently 
emphasized. Endothelial cells of donor origin were found in two sequential series of 
transbronchial biopsies of HSCT patients 
11
. In skin biopsies we only found donor-derived 
endothelial cells in HSCT patients with GVHD, and the number of chimeric cells was linked 
to the severity of GVHD induced cell damage 
12
. Particularly relevant to the GVHD-induced 
apoptotic damage is the recent in vitro demonstration that apoptotic bodies from endothelial 
cells enhance the number and initiate the differentiation of human endothelial progenitor cells 
in vitro 
13
.  
 As stated by Majhail, the current etiopathogenic paradigm for DAH is based on non 
transplantation DAH in systemic vasculitides and collagen vascular disease. Even on these 
DAH non related to transplantation, no pathological study of early events is available in 
humans. Therefore systematic studies of pure allogeneic reactions induced in animal models 
could help identifying the participation of acute GVHD in the alveolar hemorrhages following 
HSCT. 
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Figure 1 
a) Focal alveolar hemorrhage (arrows) in early lesions of allogenic reaction, b) diffuse 
alveolar damage in severe acute allogeneic reaction, and c) ultra-structural aspect of capillary 
basement membrane rupture (arrows). 
 
